SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is trending after announcing $2.8 billion in new multi-year AI cloud contracts, which bolstered confidence in its growth trajectory by raising its year-end ARR target to over $4 billion. The community is actively debating the stock's significant short interest and the company's ability to convert its massive pipeline into recognized revenue versus the risks of share dilution.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors digest a major partnership with Microsoft to deploy its Helios AI infrastructure on Azure, fueling community speculation about the stock's future performance. Discussions are heavily focused on the stock's recent volatility and technical support levels, with traders debating whether this development signals a sustained turnaround or if the stock remains vulnerable to broader semiconductor sector rotation.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending following NVIDIAs disclosure of a 9.3% passive stake, which community members are interpreting as a major vote of confidence in the company's long-term AI infrastructure potential. While some traders view the news as a catalyst for a short squeeze or a move toward new price targets, others are debating whether the stake represents new investment or simply updated regulatory reporting of existing warrant agreements.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is facing significant volatility as investors debate the company's valuation versus its long-term potential in the quantum computing space, with community discussions heavily split between optimism over government contracts and skepticism regarding its lack of organic revenue. Traders are closely monitoring the company's technical support levels and upcoming earnings report for a potential catalyst to move past recent price swings.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors aggressively position ahead of a critical earnings report, with the market intensely focused on whether the company's massive AI capital expenditure will translate into clear monetization and cloud growth. While analysts remain divided over potential model development delays versus Alphabet's dominant search and cloud ecosystem, community sentiment is highly polarized, fueling intense debate regarding the sustainability of the AI infrastructure rally.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is experiencing significant volatility as investors weigh strong long-term AI infrastructure demand against a broader market sell-off impacting the data center sector. The community remains deeply divided, with many long-term holders treating the current price drop as a discount buying opportunity while others express frustration over the lack of near-term price recovery.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors react to the company's submission of a key patent for Miplyffa to the FDA's Orange Book, which significantly reinforces long-term exclusivity through 2041. The community is actively discussing the stock's improved fundamental outlook, recent analyst price target upgrades, and speculation regarding potential interest from larger biotech firms.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending amid a high-volatility semiconductor sector sell-off, driven by investor concerns over AI infrastructure spending, geopolitical tensions in the Middle East, and liquidations linked to broader market rebalancing. Community discussions are heavily divided between opportunistic buyers viewing the decline as a major buying opportunity and bearish traders betting on a deeper correction based on fundamental valuation concerns.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

Tema Space Innovators ETF (NASA) is experiencing significant downward pressure as capital rotates heavily into the newly public SpaceX, causing institutional selling across the broader space sector and challenging the fund's current NAV. Despite the intense volatility and community frustration regarding recent performance, investors remain focused on the fund's long-term potential and its strategic exposure to the evolving space economy through top holdings like Rocket Lab and AST SpaceMobile.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is facing significant downward pressure as investors navigate the fallout from the TopBuild acquisition, which has triggered heavy selling from former shareholders and concerns over share dilution. While community sentiment remains divided between frustrated bagholders and long-term bulls betting on Brad Jacobs' track record, many are calling for better management communication and waiting for institutional accumulation to stabilize the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AI Energy Pivot Complete: LIXTE Biotechnology Finishes Corporate Rebrand to NOMAD Power Solutions, Begins Trading Under Nasdaq: NMAD

AI Energy Pivot Complete: LIXTE Biotechnology Finishes Corporate Rebrand to NOMAD Power Solutions, Begins Trading Under Nasdaq: NMAD AI Energy Pivot Complete: LIXTE Biotechnology Finishes Corporate Rebrand to NOMAD Power Solutions, Begins Trading Under Nasdaq: NMAD PR Newswire BOCA RATON, Fla...

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch PR Newswire BOCA RATON, Fla., June 12, 2026 Issued on behalf of LIXTE Biotechnology Holdings, Inc.One of the most dramatic corporate...

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Unlocking New Potential in Precision Cancer Treatment

LIXTE Biotechnology Holdings (NASDAQ: LIXT)&#160;is advancing the precision oncology landscape, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. “The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects,” reads a recent article. [&#8230;]

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape

Boca Raton, Florida-based&#160;LIXTE Biotechnology Holdings (NASDAQ: LIXT)&#160;spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100, a first-in-class inhibitor of protein phosphatase 2A (‘PP2A’),” a recent article reads. “Rather than replacing established cancer therapies, LB-100 is designed to enhance their effectiveness. [&#8230;]

LIXTE Biotechnology (NASDAQ: LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference

LIXTE Biotechnology Holdings (NASDAQ: LIXT),&#160;a clinical-stage pharmaceutical company advancing cancer treatments, announced preliminary results from a clinical trial evaluating its proprietary compound LB-100 in combination with&#160;dostarlimab&#160;at the 2026 Society of Gynecologic Oncology conference in San Juan, Puerto Rico. Interim data from 20 evaluable patients showed a 40% disease control rate and encouraging survival trends with [&#8230;]

Lixte Biotech Holdings (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

Lixte Biotechnology (NASDAQ: LIXT)&#160;is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of its [&#8230;]

LIXTE Biotechnology (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing&#8230; [&#8230;]

LIXTE Biotechnology (NASDAQ: LIXT) Strengthens Oncology Pipeline Through Expanded LB-100 Clinical Trials

Ovarian clear cell carcinoma and metastatic colon cancer remain among the most challenging malignancies to treat, with limited effective therapies and poor patient outcomes driving the urgent need for new approaches. LIXTE Biotechnology Holdings (NASDAQ: LIXT) is dedicated to addressing that need through the continued development of its lead compound LB-100. Recent updates from the company highlight expanding clinical [&#8230;]

Lixte Biotech (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Position Through Liora Technologies Partnership

Lixte Biotech Holdings (NASDAQ: LIXT)&#160;is advancing the frontiers of precision oncology, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects. By focusing on [&#8230;]

Nomad Power Solutions, Inc. engages in providing an AI energy infrastructure equipment and services platform. It focuses on delivering scalable, reliable, and efficient power generation and energy solutions. The company was founded on May 24, 2005 and is headquartered in Waterbury, VT.

Nomad Power Solutions Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

LIXTLixte Biotechnology Holdings Inc

Fundamentals

Latest LIXT News